Toronto Dominion Bank Invests $235,000 in Liquidia Co. (NASDAQ:LQDA)

Toronto Dominion Bank purchased a new position in shares of Liquidia Co. (NASDAQ:LQDA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 20,000 shares of the company's stock, valued at approximately $235,000.

A number of other large investors also recently bought and sold shares of LQDA. Steward Partners Investment Advisory LLC acquired a new stake in shares of Liquidia during the 4th quarter worth $59,000. Summit Investment Advisors Inc. grew its position in Liquidia by 35.0% during the fourth quarter. Summit Investment Advisors Inc. now owns 6,632 shares of the company's stock valued at $78,000 after acquiring an additional 1,719 shares during the period. D. E. Shaw & Co. Inc. purchased a new position in shares of Liquidia in the 4th quarter worth about $142,000. EntryPoint Capital LLC acquired a new position in shares of Liquidia in the 4th quarter valued at about $154,000. Finally, Bayesian Capital Management LP acquired a new position in shares of Liquidia in the 4th quarter valued at about $163,000. Hedge funds and other institutional investors own 64.54% of the company's stock.

Liquidia Stock Up 0.2%

Shares of Liquidia stock traded up $0.04 during trading hours on Friday, hitting $15.04. 283,702 shares of the company's stock traded hands, compared to its average volume of 1,081,335. Liquidia Co. has a twelve month low of $8.26 and a twelve month high of $19.41. The company has a market cap of $1.29 billion, a PE ratio of -9.20 and a beta of 0.24. The stock has a 50 day simple moving average of $14.72 and a 200-day simple moving average of $13.69.

Liquidia (NASDAQ:LQDA - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported ($0.45) earnings per share for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03). Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. The business had revenue of $3.12 million for the quarter, compared to analyst estimates of $3.23 million. As a group, equities research analysts predict that Liquidia Co. will post -1.51 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on LQDA shares. Wall Street Zen upgraded shares of Liquidia from a "sell" rating to a "hold" rating in a report on Thursday, May 22nd. Raymond James increased their price objective on shares of Liquidia from $27.00 to $29.00 and gave the stock a "strong-buy" rating in a research report on Friday, May 9th. Scotiabank raised their target price on shares of Liquidia from $36.00 to $37.00 and gave the company a "sector outperform" rating in a research note on Wednesday. HC Wainwright lifted their target price on shares of Liquidia from $29.00 to $35.00 and gave the company a "buy" rating in a report on Wednesday. Finally, Wells Fargo & Company increased their price target on Liquidia from $20.00 to $23.00 and gave the company an "overweight" rating in a report on Wednesday. One analyst has rated the stock with a sell rating, one has assigned a hold rating, six have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $26.67.

Insider Transactions at Liquidia

In related news, General Counsel Russell Schundler sold 5,964 shares of Liquidia stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $13.57, for a total value of $80,931.48. Following the completion of the transaction, the general counsel now directly owns 570,301 shares in the company, valued at approximately $7,738,984.57. This trade represents a 1.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Roger Jeffs sold 14,130 shares of the business's stock in a transaction dated Monday, April 14th. The shares were sold at an average price of $13.57, for a total value of $191,744.10. Following the completion of the sale, the chief executive officer now directly owns 1,006,420 shares of the company's stock, valued at approximately $13,657,119.40. This represents a 1.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 33,138 shares of company stock valued at $450,233. 26.50% of the stock is currently owned by corporate insiders.

About Liquidia

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).